COVALON TECHNOLOGIES LTD (COV.CA) Stock News
TSX-V:COV - TSX Venture Exchange - CA22282D3022 - Common Stock - Currency: CAD
COV.CA Latest News, Press Relases and Analysis
Covalon Announces Strong Fourth Quarter and Year End Fiscal 2024 Results
Mentions: TSX
Covalon Technologies Highlights Compassionate Care Technologies at 2024 ANCC National Magnet Conference
Mentions: TSX
Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting
Mentions: TSX
Covalon Technologies Ltd. to Showcase Innovative Vascular Access Solutions at the Annual Association of Pediatric Hematology/Oncology Nurses Conference
Mentions: TSX
Covalon Announces Profitable Second Quarter Fiscal 2024 Results
Mentions: TSX
Covalon Presents Compassionate Care Technology at the Infusion Nurses Society (INS) Annual Meeting & Exhibition in Kansas City, MO
Mentions: TSX
Covalon Announces First Quarter Fiscal 2024 Results
Mentions: TSX
Covalon’s VALGuard Gains Prestigious Recognition in the British Journal of Nursing
Mentions: TSX
Covalon Presents Innovative Solutions Used in Top Hospitals at the Association for Vascular Access (AVA) Annual Scientific Meeting in Portland, OR
Mentions: TSX
Covalon to Showcase Innovative Solutions at the Prestigious ANCC National Magnet Conference in Chicago
Mentions: TSX
Life with a Central Line [WEBINAR]: Key Considerations from the Patient’s Perspective
Mentions: TSX
Covalon Showcases Compassionate Pediatric Care Solutions at 47th APHON Conference
Mentions: TSX
Premier Medical Journal Spotlights Covalon’s VALGUARD: A Novel Solution to Long-Standing Problem of Protecting Vascular Access Sites
Mentions: TSX
Covalon Announces Participation in Oley Conference in St. Louis, Missouri on June 27 – 30, 2023
Mentions: TSX
Covalon Announces Participation in APIC Annual Conference & Exposition on June 26 – 28, 2023 in Orlando, Florida
Mentions: TSX
Webinar on Addressing MARSI in Vascular Access: The Role of Skin Integrity in Infection Prevention, Presented by Covalon
Mentions: TSX
Breakthrough Solution for Fragile Skin: Covalon’s IV Clear® Dressing Recommended by Physicians at a Top 10 U.S. Children’s Hospital and Epidermolysis Bullosa Center of Excellence
Mentions: TSX
Covalon, Leader in Compassionate Pediatric Infection Prevention Solutions, to Participate in Neonatal/Fetal Conference in Columbus, Ohio on May 17 - 19, 2023
Mentions: TSX
Keynotes, Educational Panels and 88 Companies to Present at the Planet MicroCap Showcase on May 3-5, 2022 at Bally's Hotel & Casino in Las Vegas, NV
LOS ANGELES, CA / ACCESSWIRE / April 27, 2022 / SNN Network presents the Planet MicroCap Showcase taking place on May 3-5, 2022, where 88 MicroCap public and private companies will be presenting at Bally's Hotel & Casino in Las Vegas, NV. Event website: www.PlanetMicroCapShowcase.com The Planet MicroCap Showcase begins on Tuesday, May 3, 2022 with the "MicroCap Investing Workshop" starting at 12:00pm PST and featuring well-known financial
Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021
LOS ANGELES, CA / ACCESSWIRE / December 6, 2021 / The SNN Network Canada Virtual Event will take place on December 7-9, 2021, where 70 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor audience. The SNN Network Canada Virtual Event begins on Tuesday, December 7, 2021 with the "MicroCap Investing Workshop" starting at 8:00am EST and featuring well-known financial influencers,
Covalon Technologies to Present at the SNN Network Canada Virtual Event on Wednesday, December 8, 2021
MISSISSAUGA, ON / ACCESSWIRE / December 3, 2021 / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV)(OTCQX:CVALF), an advanced medical technologies company, today announced that it will be presenting at the SNN Network Canada Virtual Event 2021 on Wednesday, December 8, 2021, at 3:30 PM EST. Brian Pedlar, Chief Executive Officer of Covalon, will be hosting the presentation and answering questions from investors. To access the live
Covalon Announces Retirement of Board Member
IIROC Trading Resumption - COV
IIROC Trading Halt - COV
Covalon Announces Voting Results from Fiscal 2020 Annual and Special Meeting of Shareholders
Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2021 Financial Results
Covalon Announces Conference Call to Discuss First Quarter Financial Results
Covalon Initiates Strategic Review to Enhance Shareholder Value
Covalon Announces Conference Call to Discuss Third Quarter Financial Results
Covalon Provides Business Update
Covalon Granted Key Antimicrobial Patents in the United States, Canada, and Europe
Covalon Delays Filing of Interim Financial Statements Due to Delays Related to COVID-19 and Provides Business Update